D. E. SHAW & CO, L.P.

Holdings History for Keros Therapeutics, Inc. - Common Stock, $0.0001 par value per share (KROS)

Symbol: KROS on Nasdaq
Investment type: Equity / Common Stock, $0.0001 par value per share
Latest Disclosed Shares Owned: 756,156 shares
Security Ownership %: 3.9%

D. E. Shaw & Co., L.P. ownership in Keros Therapeutics, Inc. Common Stock, $0.0001 par value per share (KROS)

17 Feb 2026 - D. E. Shaw & Co., L.P. has filed an SCHEDULE 13G/A form with the Securities and Exchange Commission (SEC) disclosing ownership of 756,156 shares of Keros Therapeutics, Inc. Common Stock, $0.0001 par value per share (KROS). This represents 3.9% ownership of the company. In their previous filing dated 27 Oct 2025, D. E. SHAW & CO, L.P. had reported owning 1,545,948 shares, indicating a decrease of +51%. .

Reporting Name	Ownership %	Change	Value $	Shares owned	Change	Activity %	Price	Form	Report date	Filing time
D. E. Shaw & Co., L.P.	3.9%	-24%	$14,745,042	756,156	-789,792	-51%	$19.50	13G/A	31 Dec 2025	17 Feb 2026, 16:05
D. E. Shaw & Co., L.P.	5.1%		$24,457,052	1,545,948			$15.82	13G	20 Oct 2025	27 Oct 2025, 16:05